Rankings
▼
Calendar
UTHR FY 2009 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
UTHR
United Therapeutics Corporation
$24B
FY 2009 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$370M
+31.4% YoY
Gross Profit
$325M
87.7% margin
Operating Income
$26M
7.0% margin
Net Income
$19M
5.3% margin
EPS (Diluted)
$0.35
Cash Flow
Operating Cash Flow
$98M
Free Cash Flow
$2M
Stock-Based Comp.
$101M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$399M
Stockholders' Equity
$653M
Cash & Equivalents
$100M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$370M
$281M
+31.4%
Gross Profit
$325M
$251M
+29.1%
Operating Income
$26M
-$82M
+131.7%
Net Income
$19M
-$43M
+145.5%
← FY 2008
All Quarters
FY 2010 →